Tagmose; Lena

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tagmose; Lena.The latest application filed is for "antibodies specific for hyperphosphorylated tau and methods of use thereof".

Company Profile

8.12.17

Tagmose; Lena - Lyngby DK
Tagmose; Lena - Valby DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20220177557 - Pedersen; Jan Torleif ; et al.	2022-06-09
Antibodies specific for hyperphosphorylated tau and methods of use thereof Grant 11,111,290 - Pedersen , et al. September 7, 2	2021-09-07
Antibodies specific for hyperphosphorylated tau and methods of use thereof Grant 10,647,762 - Pedersen , et al.	2020-05-12
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20200109192 - Pedersen; Jan Torleif ; et al.	2020-04-09
2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 inhibitors Grant 10,603,310 - Juhl , et al.	2020-03-31
Antibodies specific for hyperphosphorylated tau and methods of use thereof Grant 10,487,142 - Pedersen , et al. Nov	2019-11-26
Antibodies specific for hyperphosphorylated tau and methods of use Grant 10,472,415 - Pedersen , et al. Nov	2019-11-12
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20190284266 - Pedersen; Jan Torleif ; et al.	2019-09-19
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20190284265 - Pedersen; Jan Torleif ; et al.	2019-09-19
2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- Es As Bace1 Inhibitors App 20190000823 - Juhl; Karsten ; et al.	2019-01-03
2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyri- Dines As Bace1 Inhibitors App 20180244645 - JUHL; Karsten ; et al.	2018-08-30
2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease Grant 10,059,669 - Juhl , et al. August 28, 2	2018-08-28
2-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors Grant 10,058,540 - Juhl , et al. August 28, 2	2018-08-28
2-amino-7a-phenyl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines As Bace1 Inhibitors App 20180230160 - Juhl; Karsten ; et al.	2018-08-16
2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 inhibitors Grant 10,045,974 - Juhl , et al. August 14, 2	2018-08-14
6-amino-5-fluoro-5-(fluoromethyl)-2,3,4,5-tetrahydropyridin-2-yl-phenyl-5-- (methoxy-d3)-pyrazine-2-carboxamides And Fluorinated Derivatives Thereof As Bace1 Inhibitors App 20180186769 - Juhl; Karsten ; et al.	2018-07-05
2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyri- dines as BACE1 inhibitors Grant 10,011,596 - Juhl , et al. July 3, 2	2018-07-03
Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines Grant 10,004,738 - Juhl , et al. June 26, 2	2018-06-26
Antibodies Specific for Hyperphosphorylated Tau and Methods of Use Thereof App 20180016330 - Pedersen; Jan Torleif ; et al.	2018-01-18
2-Amino-5,5-Difluoro-6-(Fluoromethyl)-6-Phenyl-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors App 20170340618 - Juhl; Karsten ; et al.	2017-11-30
2-Amino-6-(Difluoromethyl)-5,5-Difluoro-6-Phenyl-3,4,5,6-Tetrahydropyridin- es as BACE1 Inhibitors App 20170319564 - Juhl; Karsten ; et al.	2017-11-09
2-Amino-3,5-Difluoro-3,6-Dimethyl-6-Phenyl-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treating Alzheimer's Disease App 20170313658 - JUHL; Karsten ; et al.	2017-11-02
2-Amino-3,5,5-Trifluoro-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treatment of Alzheimer's Disease App 20170066741 - Juhl; Karsten ; et al.	2017-03-09
Combination Treatment Comprising Administration of 2-Amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines App 20170042895 - Juhl; Karsten ; et al.	2017-02-16
2-Amino-3-Fluoro-3-(Fluoromethyl)-6-Methyl-6-Phenyl-3,4,5,6-Tetrahydropyri- dines as BACE1 Inhibitors App 20170044151 - Juhl; Karsten ; et al.	2017-02-16
2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease Grant 9,353,084 - Juhl , et al. May 31, 2	2016-05-31
2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 inhibitors Grant 9,346,797 - Juhl , et al. May 24, 2	2016-05-24
2-Amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 Inhibitors App 20160130267 - Juhl; Karsten ; et al.	2016-05-12
2-Amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease App 20150232449 - Juhl; Karsten ; et al.	2015-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.